Completed NA INTERVENTIONAL 1-arm NCT00314275

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System (ENDEAVOR PK)

Evaluation of Pharmacokinetics (PK) and Safety of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions

Sponsor: Medtronic Vascular

Conditions Coronary Artery Disease

Interventions Coronary Artery Stenting Endeavor

Updated 6 times since 2017 Last updated: Apr 19, 2012 Started: Jan 31, 2006 Primary completion: May 31, 2006 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Medtronic Vascular and has accumulated 6 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Vascular

Data source: Medtronic Vascular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santa Rosa, United States